Shawna Klahn

577 total citations
18 papers, 325 citations indexed

About

Shawna Klahn is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Biomedical Engineering. According to data from OpenAlex, Shawna Klahn has authored 18 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 6 papers in Genetics and 4 papers in Biomedical Engineering. Recurrent topics in Shawna Klahn's work include Veterinary Oncology Research (12 papers), Virus-based gene therapy research (6 papers) and Ultrasound and Hyperthermia Applications (4 papers). Shawna Klahn is often cited by papers focused on Veterinary Oncology Research (12 papers), Virus-based gene therapy research (6 papers) and Ultrasound and Hyperthermia Applications (4 papers). Shawna Klahn collaborates with scholars based in United States, Australia and Canada. Shawna Klahn's co-authors include Nikolaos Dervisis, James H. Southard, Timothy M. Piazza, Martin J. Mangino, José Torrealba, Hannah V. Carey, Susanne L. Lindell, Barbara E. Kitchell, Sheryl Coutermarsh‐Ott and Joanne Tuohy and has published in prestigious journals such as IEEE Transactions on Biomedical Engineering, American Journal of Physiology-Gastrointestinal and Liver Physiology and Ultrasound in Medicine & Biology.

In The Last Decade

Shawna Klahn

18 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shawna Klahn United States 9 120 63 57 56 56 18 325
Juping Wang China 13 21 0.2× 21 0.3× 234 4.1× 33 0.6× 81 1.4× 43 469
James M. Quinn United States 12 45 0.4× 63 1.0× 41 0.7× 27 0.5× 54 1.0× 30 429
Assel Biyasheva United States 7 55 0.5× 168 2.7× 181 3.2× 16 0.3× 57 1.0× 11 606
Emmanouella Tsirimonaki Greece 9 55 0.5× 12 0.2× 132 2.3× 7 0.1× 80 1.4× 13 413
Vincenzo Panasiti Italy 14 28 0.2× 31 0.5× 77 1.4× 3 0.1× 48 0.9× 51 537
Charles A. McLaughlin United States 10 65 0.5× 11 0.2× 93 1.6× 11 0.2× 22 0.4× 18 311
Oana Draghiciu Netherlands 8 36 0.3× 30 0.5× 111 1.9× 46 0.8× 31 0.6× 9 571
Bei Jia China 15 29 0.2× 26 0.4× 281 4.9× 8 0.1× 83 1.5× 36 669
Yutong Xing China 15 77 0.6× 12 0.2× 174 3.1× 14 0.3× 30 0.5× 27 446
P. Rowland United States 8 80 0.7× 13 0.2× 135 2.4× 9 0.2× 32 0.6× 10 329

Countries citing papers authored by Shawna Klahn

Since Specialization
Citations

This map shows the geographic impact of Shawna Klahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawna Klahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawna Klahn more than expected).

Fields of papers citing papers by Shawna Klahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawna Klahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawna Klahn. The network helps show where Shawna Klahn may publish in the future.

Co-authorship network of co-authors of Shawna Klahn

This figure shows the co-authorship network connecting the top 25 collaborators of Shawna Klahn. A scholar is included among the top collaborators of Shawna Klahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawna Klahn. Shawna Klahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Coutermarsh‐Ott, Sheryl, et al.. (2023). Histotripsy ablation for the treatment of feline injection site sarcomas: a first-in-cat in vivo feasibility study. International Journal of Hyperthermia. 40(1). 2210272–2210272. 8 indexed citations
2.
Klahn, Shawna, et al.. (2023). Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma. Veterinary and Comparative Oncology. 21(4). 709–716. 3 indexed citations
3.
Klahn, Shawna, et al.. (2023). A review of the development of histotripsy for extremity tumor ablation with a canine comparative oncology model to inform human treatments. International Journal of Hyperthermia. 40(1). 2274802–2274802. 2 indexed citations
4.
Klahn, Shawna, et al.. (2023). Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies. Frontiers in Veterinary Science. 9. 1046636–1046636. 19 indexed citations
5.
Gannon, Jessica M., Sheryl Coutermarsh‐Ott, Timothy J. Ziemlewicz, et al.. (2022). Mechanical High-Intensity Focused Ultrasound (Histotripsy) in Dogs With Spontaneously Occurring Soft Tissue Sarcomas. IEEE Transactions on Biomedical Engineering. 70(3). 768–779. 15 indexed citations
6.
Carroll, Jennifer L., Sheryl Coutermarsh‐Ott, Shawna Klahn, et al.. (2022). High intensity focused ultrasound for the treatment of solid tumors: a pilot study in canine cancer patients. International Journal of Hyperthermia. 39(1). 855–864. 8 indexed citations
7.
8.
Coutermarsh‐Ott, Sheryl, Jessica M. Gannon, Nikolaos Dervisis, et al.. (2021). Histotripsy Ablation of Bone Tumors: Feasibility Study in Excised Canine Osteosarcoma Tumors. Ultrasound in Medicine & Biology. 47(12). 3435–3446. 29 indexed citations
9.
Carroll, Jennifer L., Nikolaos Dervisis, Sheryl Coutermarsh‐Ott, et al.. (2021). Focused ultrasound tumour ablation in small animal oncology. Veterinary and Comparative Oncology. 19(3). 411–419. 5 indexed citations
10.
Tuohy, Joanne, et al.. (2020). Clinical outcomes in dogs with localized splenic histiocytic sarcoma treated with splenectomy with or without adjuvant chemotherapy. Journal of Veterinary Internal Medicine. 34(6). 2645–2650. 7 indexed citations
11.
Klahn, Shawna, et al.. (2019). Identification of the JAK-STAT pathway in canine splenic hemangiosarcoma, thyroid carcinoma, mast cell tumor, and anal sac adenocarcinoma. Veterinary Immunology and Immunopathology. 220. 109996–109996. 4 indexed citations
12.
Smith, Annette, et al.. (2018). ACVIM small animal consensus statement on safe use of cytotoxic chemotherapeutics in veterinary practice. Journal of Veterinary Internal Medicine. 32(3). 904–913. 14 indexed citations
13.
Klahn, Shawna, et al.. (2018). Hemophagocytic syndrome in a cat. Journal of Feline Medicine and Surgery Open Reports. 4(2). 837462799–837462799. 5 indexed citations
14.
Dervisis, Nikolaos & Shawna Klahn. (2016). Therapeutic Innovations: Tyrosine Kinase Inhibitors in Cancer. Veterinary Sciences. 3(1). 4–4. 16 indexed citations
15.
Klahn, Shawna. (2014). Chemotherapy Safety in Clinical Veterinary Oncology. Veterinary Clinics of North America Small Animal Practice. 44(5). 941–963. 8 indexed citations
16.
Rossmeisl, John H., Paulo Alonso Gaona-García, Gregory B. Daniel, et al.. (2013). INVITED REVIEW—NEUROIMAGING RESPONSE ASSESSMENT CRITERIA FOR BRAIN TUMORS IN VETERINARY PATIENTS. Veterinary Radiology & Ultrasound. 55(2). 115–132. 25 indexed citations
17.
Klahn, Shawna, Barbara E. Kitchell, & Nikolaos Dervisis. (2011). Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma. Journal of the American Veterinary Medical Association. 239(1). 90–96. 41 indexed citations
18.
Lindell, Susanne L., Shawna Klahn, Timothy M. Piazza, et al.. (2005). Natural resistance to liver cold ischemia-reperfusion injury associated with the hibernation phenotype. American Journal of Physiology-Gastrointestinal and Liver Physiology. 288(3). G473–G480. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juping Wang Breakdown of academic impact, for papers by James M. Quinn Breakdown of academic impact, for papers by Assel Biyasheva Breakdown of academic impact, for papers by Emmanouella Tsirimonaki Breakdown of academic impact, for papers by Vincenzo Panasiti Breakdown of academic impact, for papers by Charles A. McLaughlin Breakdown of academic impact, for papers by Oana Draghiciu Breakdown of academic impact, for papers by Bei Jia Breakdown of academic impact, for papers by Yutong Xing Breakdown of academic impact, for papers by P. Rowland
Rankless by CCL
2026